Stocktoria
PMV Pharmaceuticals, Inc. PMVP
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2020-09-25
PMV Pharmaceuticals, Inc. statistics & valuation
Market cap$63.5M
P / B0.6×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Return on assets | -66.7% | -30.7% | -27.3% | -27.1% | -17.4% |
| Return on equity | -74.2% | -33.3% | -30.6% | -29.8% | -18.7% |
| Current ratio | 10.09 | 12.22 | 14.78 | 22.80 | 24.66 |
Source: SEC EDGAR filings · CIK 0001699382 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.